d12631

News
Treatment-Resistant Actinic Keratoses Characterized by Increased Pain, Acantholysis, and Distinct Histological Features
05/20/2021
Treatment-resistant actinic keratoses are painful and show acantholysis with distinct basal proliferation, according to a recent study.
Treatment-resistant actinic keratoses are painful and show acantholysis with distinct basal proliferation, according to a recent study.
Treatment-resistant actinic...
05/20/2021
The Dermatologist
Tirbanibulin and Actinic Keratosis
Quiz
Tirbanibulin and Actinic Keratosis
03/24/2021
Can you identify this statement about tirbanibulin and actinic keratosis as true or false?
Can you identify this statement about tirbanibulin and actinic keratosis as true or false?
Can you identify this statement...
03/24/2021
The Dermatologist
News
Study Highlights the Role of Diet in Photodynamic Therapy for Actinic Keratosis
03/04/2021
A study published in the Journal of Dermatological Treatment aimed to compare the time of skin healing and side effects in omnivores and vegans treated with photodynamic therapy (PDT) for actinic keratosis (AK).
A study published in the Journal of Dermatological Treatment aimed to compare the time of skin healing and side effects in omnivores and vegans treated with photodynamic therapy (PDT) for actinic keratosis (AK).
A study published in the Journal...
03/04/2021
The Dermatologist
News
Phase 3 Trial Finds Tirbanibulin Effective for AKs, More Long-term Data Needed
02/23/2021
A study published in New England Journal of Medicine found tirbanibulin was superior to vehicle as a topical treatment for actinic keratoses but was associated with transient localized reactions and recurrence at 1 year.
A study published in New England Journal of Medicine found tirbanibulin was superior to vehicle as a topical treatment for actinic keratoses but was associated with transient localized reactions and recurrence at 1 year.
A study published in New England...
02/23/2021
The Dermatologist
News
FDA Approves New Topical Treatment for Actinic Keratosis
01/25/2012
Ingenol mebutate (Picato) gel (0.015%, 0.05%) is the first and only topical AK therapy that can be used for as little as 2 or 3 days.
Ingenol mebutate (Picato) gel (0.015%, 0.05%) is the first and only topical AK therapy that can be used for as little as 2 or 3 days.
Ingenol mebutate (Picato) gel...
01/25/2012
The Dermatologist
News
PhotoMedex and Galderma to Co-Promote Actinic Keratosis Treatment
01/11/2010
PhotoMedex and Galderma Laboratories, LP, have entered into a co-promotion agreement for Galderma’s photodynamic therapy application for the treatment of actinic keratoses (AKs). Under the terms of the agreement, the sales force at PhotoMedex...
PhotoMedex and Galderma Laboratories, LP, have entered into a co-promotion agreement for Galderma’s photodynamic therapy application for the treatment of actinic keratoses (AKs). Under the terms of the agreement, the sales force at PhotoMedex...
PhotoMedex and Galderma...
01/11/2010
The Dermatologist
News
Treating AKs: What Are Your Best Options?
09/04/2008
Reducing Irritation While Effectively Treating AKs A new combination approach between topical 5-FU and hydrocortisone butyrate 0.1% lipocream. Traditionally, 5-fluorouracil (5-FU) cream is one modality that has been effectively used as a...
Reducing Irritation While Effectively Treating AKs A new combination approach between topical 5-FU and hydrocortisone butyrate 0.1% lipocream. Traditionally, 5-fluorouracil (5-FU) cream is one modality that has been effectively used as a...
Reducing Irritation While...
09/04/2008
The Dermatologist

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use